VIVEbiotech is participating in the ESGCT Annual Congress taking place in Brussels this week
VIVEbiotech is participating in the ESGCT (European Society of Gene and Cell Therapy) Annual Congress taking place in Brussels this week.
The 30th Annual Congress has been organized together with the French Society for Cell and Gene Therapy (SFTCG) and the Netherlands Society of Gene and Cell Therapy (NVGCT).
VIVEbiotech is a Silver Sponsor and is exhibiting at booth number 35.
VIVEbiotech’s researchers are showcasing their work:
- Marie Fertin, on one hand, is presenting poster nr 229 entitled “Lentiviral CAR-T backbone promotor configuration determine vector production yield and vector functionality by modulating viral genome production and packaging yields”.
- Soledad Baños Mateos, on the other, will be presenting poster nr 252 with the title “Abolishing retro-transduction of producer cells in lentiviral vector manufacturing“.
Please come visit the team to learn more about our lentiviral vector development and manufacturing services.